Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
Ellies
Maik
M
Department of Otorhinolaryngology-Head and Neck Surgery, University of Göttingen, Robert-Koch-Strasse 40, D-37075 Göttingen, Germany. melliues@med.uni-goettingen.de
Gottstein
Ulrike
U
Rohrbach-Volland
Saskia
S
Arglebe
Christian
C
Laskawi
Rainer
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002648:Child; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D012189:Retrospective Studies; D012467:Salivary Gland Fistula / Q000188:drug therapy*; D012472:Salivation / Q000187:drug effects; D012793:Sialadenitis / Q000188:drug therapy*; D012798:Sialorrhea / Q000188:drug therapy*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A